Friday, December 04, 2020 12:07:20 AM
"A Novel Peptide Immunotherapy to Treat Severe, Late Stage SARS-COV-2 Infection
Principal Investigator: M. Karen Newell-Rogers, Ph.D., College of Medicine, Texas A&M University
Project Summary: This DOD application proposes to study an immunotherapy, Competitive Antagonist Peptide (CAP), to treat life-threatening symptoms associated with severe COVID19. The rationale for use of CAP to fight COVID-19-syndromes is based on CAP’s dual capabilities to: (1) treat and resolve hyper-inflammation by reducing inflammatory cytokines (IL-1beta, IL-6, TNFalpha); and (2) expand CD8+ T cells. CAP's anti-inflammatory properties have been demonstrated in 4 pre-clinical models of inflammatory disease."
Could this be $ENZC going for the Late Stage problem that Lilly and REGN both tapped out on? Both LLY AND REGN stopped their clinical trials for late stage.
https://vpr.tamu.edu/research-index-for-covid-19
WHOA!!!!
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
PickleJar Debuts Nationwide Contest With Brian Kelley for Fans to Win a Three-Day Bahama Cruise • NREG • Jun 3, 2024 8:45 AM
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM